Insider Buying and Selling - TEVA

Transaction	Filed	Name	Type	Shares @ Price	Value	Balance change		Ownership
03/17/2026	03/19/2026	Sabag Mark Executive Vice President, International Markets Co Officer	Sell	-62,102 @ $30.14	($1,871,816.38)	224,940	(-21.64%)	Direct
02/26/2026 10b5-1	03/02/2026	Kalif Eliyahu Sharon EVP, Chief Financial Officer CFO	Sell	-345,810 @ $33.64	($11,634,708.29)	57,478	(-85.75%)	Direct
12/16/2025	12/18/2025	Weiss Amir Chief Accounting Officer Officer	Sell	-12,300 @ $30.20	($371,504.28)	5,650	(-68.52%)	Direct
11/14/2025	11/18/2025	Fox Christine EVP, Head of U.S. Commercial Officer	Sell	-30,000 @ $25.11	($753,321.00)	28,384	(-51.38%)	Direct
11/06/2025	11/10/2025	Weiss Amir Chief Accounting Officer Officer	Sell	-12,300 @ $24.44	($300,564.03)	17,950	(-40.66%)	Direct
09/05/2025	09/09/2025	Mcavoy David R. EVP, Chief Legal Officer Officer	Buy	1,113 @ $18.86	$20,988.06	13,027	(9.34%)	Direct
06/12/2025 10b5-1	06/16/2025	Kalif Eliyahu Sharon EVP, Chief Financial Officer CFO	Sell	-55,775 @ $17.08	($952,464.10)	403,288	(-12.15%)	Direct
05/08/2025	05/12/2025	Sabag Mark Executive Vice President, International Markets Co Officer	Sell	-337,915 @ $18.04	($6,097,304.47)	150,996	(-69.12%)	Direct

Teva Pharmaceutical Industries Ltd - TEVA